NAC (N-Acetyl Cysteine) — Stack & Timing
Educational timing and stacking information based on how NAC (N-Acetyl Cysteine) has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how NAC (N-Acetyl Cysteine) has been studied and commonly used.
Commonly studied timing
NAC is commonly taken in the morning with food to minimize gastrointestinal discomfort; post-workout timing has been explored in recovery-focused trials to address exercise-induced oxidative stress, though no single timing has been definitively established as superior.
Dose ranges used in studies
Clinical trials and expert sources consistently use doses in the 600–1800 mg/day range, often split into two doses; the GlyNAC RCT and COPD exacerbation trial fall within this window, and expert commentators including Huberman and Patrick align with the lower-to-mid portion of this range.
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Glycine and NAC together provide both precursors needed for glutathione synthesis; the GlyNAC combination has been studied specifically for improving glutathione deficiency, oxidative stress, and aging-related hallmarks in older adults.
Co-administration has been explored for modulating immune aging (immunosenescence), particularly in older adults who are vitamin D deficient.
Both are antioxidants that support glutathione recycling; Vitamin C can help regenerate oxidized glutathione, potentially complementing NAC's role as a glutathione precursor.
ALA also supports glutathione synthesis and recycling and works synergistically with NAC as part of a broader antioxidant defense strategy.
Safety & interactions
NAC is generally well-tolerated at studied doses, but gastrointestinal side effects (nausea, vomiting, diarrhea) are the most commonly reported; very high intravenous doses used in clinical settings (e.g., acetaminophen overdose treatment) carry different risk profiles than oral supplementation. Long-term high-dose oral use has not been extensively studied in healthy populations.
- •Nitroglycerin and other nitrate medications: NAC may potentiate vasodilatory effects, potentially causing hypotension and headache
- •Activated charcoal: may reduce oral NAC absorption if co-administered
- •Immunosuppressants: theoretical interaction due to NAC's immune-modulating properties warrants caution
- •Anticoagulants (e.g., warfarin): some evidence suggests NAC may have mild antiplatelet/anticoagulant properties, warranting monitoring
Individuals with asthma should use caution as inhaled NAC can cause bronchospasm (less relevant for oral forms); those with active peptic ulcers or a history of cystinuria (cystine kidney stones) should consult a physician before use; pregnant or breastfeeding individuals should seek medical advice prior to supplementation.